These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7475093)

  • 1. A model of non-exclusive binding of agonist and antagonist on G-protein coupled receptors.
    Järv J
    J Theor Biol; 1995 Aug; 175(4):577-82. PubMed ID: 7475093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compartmentation of receptors and guanine nucleotide-binding proteins in NG108-15 cells: lack of cross-talk in agonist binding among the alpha 2-adrenergic, muscarinic, and opiate receptors.
    Graeser D; Neubig RR
    Mol Pharmacol; 1993 Mar; 43(3):434-43. PubMed ID: 8095695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tiotidine, a histamine H2 receptor inverse agonist that binds with high affinity to an inactive G-protein-coupled form of the receptor. Experimental support for the cubic ternary complex model.
    Monczor F; Fernandez N; Legnazzi BL; Riveiro ME; Baldi A; Shayo C; Davio C
    Mol Pharmacol; 2003 Aug; 64(2):512-20. PubMed ID: 12869657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ligand-receptor-G-protein ternary complex as a GTP-synthase. steady-state proton pumping and dose-response relationships for beta -adrenoceptors.
    Broadley KJ; Nederkoorn PH; Timmerman H; Timms D; Davies RH
    J Theor Biol; 2000 Jul; 205(2):297-320. PubMed ID: 10873440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G protein activation by G protein coupled receptors: ternary complex formation or catalyzed reaction?
    Roberts DJ; Waelbroeck M
    Biochem Pharmacol; 2004 Sep; 68(5):799-806. PubMed ID: 15294442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biased inhibition by a suramin analogue of A1-adenosine receptor/G protein coupling in fused receptor/G protein tandems: the A1-adenosine receptor is predominantly coupled to Goalpha in human brain.
    Kudlacek O; Waldhoer M; Kassack MU; Nickel P; Salmi JI; Freissmuth M; Nanoff C
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Jan; 365(1):8-16. PubMed ID: 11862328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscarinic receptor function, density and G-protein coupling in the overactive diabetic rat bladder.
    Stevens LA; Sellers DJ; McKay NG; Chapple CR; Chess-Williams R
    Auton Autacoid Pharmacol; 2006 Jul; 26(3):303-9. PubMed ID: 16879496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand binding model for G-protein-linked receptors: an update.
    Saunders J
    Drug Des Discov; 1993; 9(3-4):213-20. PubMed ID: 8104519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of partial agonists and Mg2+ ions on the interaction of M2 muscarinic acetylcholine receptor and G protein Galpha i1 subunit in the M2-Galpha i1 fusion protein.
    Zhang Q; Okamura M; Guo ZD; Niwa S; Haga T
    J Biochem; 2004 May; 135(5):589-96. PubMed ID: 15173197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An arginine residue conserved in most G protein-coupled receptors is essential for the function of the m1 muscarinic receptor.
    Zhu SZ; Wang SZ; Hu J; el-Fakahany EE
    Mol Pharmacol; 1994 Mar; 45(3):517-23. PubMed ID: 8145736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes.
    Odagaki Y; Toyoshima R
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1304-12. PubMed ID: 16824659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the critical domains of the delta-opioid receptor involved in G protein coupling using site-specific synthetic peptides.
    Merkouris M; Dragatsis I; Megaritis G; Konidakis G; Zioudrou C; Milligan G; Georgoussi Z
    Mol Pharmacol; 1996 Oct; 50(4):985-93. PubMed ID: 8863845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational design of receptor partial agonists and possible mechanisms of receptor partial activation: a theory.
    Zhu BT
    J Theor Biol; 1996 Aug; 181(3):273-91. PubMed ID: 8869127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonist high and low affinity state ratios predict drug intrinsic activity and a revised ternary complex mechanism at serotonin 5-HT(2A) and 5-HT(2C) receptors.
    Egan C; Grinde E; Dupre A; Roth BL; Hake M; Teitler M; Herrick-Davis K
    Synapse; 2000 Feb; 35(2):144-50. PubMed ID: 10611640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of alpha 2-adrenergic receptor activation of G proteins: evidence for a precoupled receptor/G protein state.
    Tian WN; Duzic E; Lanier SM; Deth RC
    Mol Pharmacol; 1994 Mar; 45(3):524-31. PubMed ID: 8145737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the binding distribution of agonist and antagonist ligands for histamine H3 receptors in pig brain by quantitative autoradiography.
    Mezzomo K; Cumming P; Minuzzi L
    Eur J Pharmacol; 2007 Jun; 564(1-3):75-9. PubMed ID: 17350614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of models for analysis of radioligand binding data.
    Abramson SN; McGonigle P; Molinoff PB
    Mol Pharmacol; 1987 Jan; 31(1):103-11. PubMed ID: 3027522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of an agonistic binding site for blockers of the M(3) muscarinic acetylcholine receptor.
    Thor D; Schulz A; Hermsdorf T; Schöneberg T
    Biochem J; 2008 May; 412(1):103-12. PubMed ID: 18237275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta gamma subunits of guanine nucleotide-binding proteins and regulation of spontaneous receptor activity: thermodynamic model for the interaction between receptors and guanine nucleotide-binding protein subunits.
    Onaran HO; Costa T; Rodbard D
    Mol Pharmacol; 1993 Feb; 43(2):245-56. PubMed ID: 8381511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A peptide agonist acts by occupation of a monomeric G protein-coupled receptor: dual sites of covalent attachment to domains near TM1 and TM7 of the same molecule make biologically significant domain-swapped dimerization unlikely.
    Hadac EM; Ji Z; Pinon DI; Henne RM; Lybrand TP; Miller LJ
    J Med Chem; 1999 Jun; 42(12):2105-11. PubMed ID: 10377216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.